Mediolanum International Funds Ltd

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 2022028 DUBLIN 1, L2

Position in REGN

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$9,199,709

-$45,819,212 QoQ

Shares Held

14,754

-79.3% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#305

of 1,322 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mediolanum International Funds Ltd holds $75,305,474 across 10 Biotechnology names. REGN ranks #3 (12.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	29,785	$27,633,629
2	ALNY	Alnylam Pharmaceuticals, Inc.	46,396	$13,966,587
3	REGN	Regeneron Pharmaceuticals, Inc. This page	14,754	$9,199,709
4	INCY	Incyte Corp	76,627	$8,686,436
5	KRYS	Krystal Biotech, Inc.	15,940	$5,924,419
6	ASND	Ascendis Pharma A/S	11,697	$3,119,823
7	VRTX	Vertex Pharmaceuticals Inc / Ma	5,776	$2,869,112
8	ARWR	Arrowhead Pharmaceuticals, Inc.	28,940	$2,358,899

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,199,709	14,754	-79.3%	Shares	Sole	2026-07-23
2026-03-31	$55,018,921	71,209	+56.4%	Shares	Sole	2026-05-06
2025-12-31	$35,147,100	45,535	+3528.3%	Shares	Sole	2026-02-09
2025-09-30	$705,648	1,255	-65.1%	Shares	Sole	2025-11-04
2025-06-30	$1,885,275	3,591	-89.2%	Shares	Sole	2025-08-12
2025-03-31	$21,069,120	33,220	+646.7%	Shares	Sole	2025-05-07
2024-12-31	$3,169,156	4,449	+5.3%	Shares	Sole	2025-01-23
2024-09-30	$4,441,489	4,225	-71.3%	Shares	Sole	2024-10-23
2024-06-30	$15,494,284	14,742	+14.6%	Shares	Sole	2024-08-13
2024-03-31	$12,383,396	12,866	—	Shares	Sole	2024-05-03
No filing history on record for this holder in this stock.